# Revolution Medicines, Inc.: insider transactions

RVMD · Nasdaq · CIK 1628171 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rvmd.md) · [Financials](/companies/rvmd/financials.md) · [Filings](/companies/rvmd/filings.md) · [Insiders](/companies/rvmd/insiders.md)

## All transactions: 2

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-26 | [Mancini Anthony](/insiders/2124509.md) | See Remarks, Officer | Sale (S) | 2,310 | $186.99 | $431.9k | [Form 4](/filings/0001193125-26-436459.md) |
| 2026-10-26 | [Mancini Anthony](/insiders/2124509.md) | See Remarks, Officer | Option exercise (M) | 2,310 | $33.62 | $77.7k | [Form 4](/filings/0001193125-26-436459.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 12:38 ET. No prices; not investment advice.